No offence guys, but pointing fingers at management for not buying on market is absurd.
Their focus is where it should be, creating shareholder value by reaching the milestones, successfully executing multiple trials in line with stringent standards and gathering data requisite for regulatory approval & commercialisation of their pipeline.
They are responsible for delivering, for patients first, and this then in turn creates shareholder value and wealth.
They are not responsible for attempting to pander to impatience & propping up a share price under immense pressure from larger macro & insto forces and poor sentiment of those lacking the intestinal fortitude for market trends
Ann: Initial Director's Interest Notice, page-35
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.002(4.65%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.5¢ | 4.3¢ | $732.0K | 16.76M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1799587 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 1003772 | 13 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |